Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000727517 | SCV000590168 | uncertain significance | not provided | 2017-05-24 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the TTN gene. The c.16128 C>T variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is observed in 9/16508 (0.05%) alleles from individuals of South Asian ancestry in the Exome Aggregation Consortium (ExAC) dataset (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.16128 C>T variant results in a synonymous change of the residue S5376 in the TTN gene. This nucleotide substitution occurs at a position that is only conserved in mammals. Several in silico splice prediction algorithms predict that this variant creates a weak cryptic splice site in exon 56 upstream of the natural splice donor site for intron 56. However, in the absence of functional mRNA studies, the physiological consequence of this variant cannot be precisely determined. Finally, other truncating TTN variants have been reported in approximately 3% of control alleles and c.16128 C>T is not located in the A-band region of titin, where the majority of truncating pathogenic variants associated with DCM have been reported (Herman et al., 2012). |
| Labcorp Genetics |
RCV000557763 | SCV000642734 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-11-27 | criteria provided, single submitter | clinical testing | |
| Eurofins Ntd Llc |
RCV000727517 | SCV000709389 | uncertain significance | not provided | 2017-06-16 | criteria provided, single submitter | clinical testing |